Moreover, we found that MEGF9 protein is expressed in 32% of tumors, a finding that could have therapeutic implications in breast cancer patients as this protein is a membrane receptor whose blockage might alter the proliferative signal. Here, MEGF9 is linked to breast carcinoma.